Skip to main content

With billions of dollars at stake, Merck and Palantir partner to discover drugs faster

 Merck, the German multinational chemical and pharmaceutical company, is teaming up with Silicon Valley’s highest-profile data and analysis software company, Palantir, to more quickly develop new drugs and, hopefully, improve patient outcomes. The idea at the start is for the companies to partner on three of Merck’s business sectors: healthcare, life sciences, and performance… Read More
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.